Navigation
Informationen für ...
Gemeinsam für studentischen Wohnraum

zimmerfrei-2.jpg

Baustelle Uni

IMG_4061_aus.jpg

Uni Bonn Online-Shop
Initiativen

audit_fgh-aus-58.jpg  E-Quality-58.jpg  U15-58.jpg

115-de.jpg
 
Sie sind hier: Startseite Press releases Significantly higher success rates with artificial insemination

Significantly higher success rates with artificial insemination

Using a special microscope \'good\' ova can be distinguished from \'bad\' ones

In future a new method could help some couples who are childless against their will. The microscopic procedure significantly improves the success rate of 'ICSI'  (intracytoplasmic sperm injection). This was discovered by scientists at the University of Bonn together with colleagues from China and industrial partners in a study of 124 women. Up to now, the desire to have a child is only fulfilled for every third couple that decides to have ICSI. In a study the artificial insemination method was twice as successful. The scientists have now published their data in the journal 'Reproductive BioMedicine'. (Online version available at http://www.rbmonline.com/Article/3161).

For many couples ICSI is the last resort in their attempt to have a child. 'The method is recommended if the man produces too few sperm cells,' the Bonn reproductive biologist Dr. Markus Montag explains. Doctors can in most cases still extract individual functioning sperm cells from testicular tissue, which they then inject into the ovum. The partner must take hormone preparations before an ICSI. They result in several ova maturing in the ovaries, normally it is only one ovum per month.

'We inject a sperm into every one of these cells,' Markus Montag explains. 'Then it takes more than 26 hours until the plasmosomes of the ovum and sperm cell fuse and an embryo forms. In this time frame we have to decide which of the fertilised ova to insert into the uterus.’ The reason for this is that the German law for the protection of embryos lays down that only a maximum of three fertilised ova are allowed to be implanted per attempt. 'We even restrict ourselves to only two, in order to exclude the possibility of births of triplets,' Markus Montag explains. With pregnancies involving multiple births there is an increased risk of miscarriages and malformations.

Choosing the 'best' ova

Which of the fertilised ova are finally implanted has usually been left up to chance. But today it is known that not all ova have the same quality. Using a special procedure the Bonn scientists can select the two most suitable candidates. 'For this we observe the ovule integument under a DIC microscope,' Dr. Montag explains. 'There it appears as a luminescent orange-red ring. The brighter this ring is and the more uniformly it shines, the greater the chance that it becomes a child.' The reason for this is that the ovule integument always seems to have a particularly uniform structure if the cell has matured under good conditions.

Normally every third ICSI is successful. But if medics used two 'good ' ova in their experiment, this rate increased to more than 50 per cent. With a 'good' and a 'bad' ovum the success rate was still around 40 per cent, using two 'bad' ones only 20 per cent. 'Mind you, two “good” ova are rare,' Markus Montag emphasises. 'Only with two out of ten cells does the ovule integument have an intense regular orange colour.'

Under natural conditions insemination takes place in the oviduct. After that the ovum begins to divide, while contractions of the oviduct transport it to the uterus. This process takes just under 2-3 days. When the embryo lodges in the endometrium on the sixth day after insemination, the embryo consists of several hundred cells. During the whole process the embryo is protected by the ovule integument.

The Bonn team led by Dr. Markus Montag and Professor Hans van der Ven has developed software in conjunction with the Octax Microscience Company, which analyses the image from the microscope objectively and proposes the most suitable cells. 'This way the procedure can be implemented in clinical routine without problems and without much  effort,' he says.


Images accompanying this press release can be found on the internet at http://www.uni-bonn.de >> Aktuelles >> Presseinformationen.

Contact person:
Dr. Markus Montag
Department of Gynaecological Endocrinology & Reproductive Medicine
Bonn University Clinic
Telephone: ++49 (0)228 287-15449
E-mail:
Markus.Montag@ukb.uni-bonn.de


Untertitel:

Dr Markus Montag uses the distribution of brightness in the ovule integument to assess how suitable the ovum is for artificial insemination.

Artikelaktionen